{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:40:05Z","timestamp":1790750405039,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Clinical Research Center for Metabolic Diseases","award":["2013BAI09B13"],"award-info":[{"award-number":["2013BAI09B13"]}]},{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program of the Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2012ZX09303006-001"],"award-info":[{"award-number":["2012ZX09303006-001"]}],"id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.diabres.2020.108080","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:02:37Z","timestamp":1581526957000},"page":"108080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Cholecystectomy is an independent factor of enhanced insulin release and impaired insulin sensitivity"],"prefix":"10.1016","volume":"162","author":[{"given":"Yun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108080_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.1840210109","article-title":"Long-term effects of cholecystectomy on bile acid metabolism","volume":"21","author":"Kullak-Ublick","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2020.108080_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1478-3231.2010.02361.x","article-title":"Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice","volume":"31","author":"Amigo","year":"2011","journal-title":"Liver. Int."},{"key":"10.1016\/j.diabres.2020.108080_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1665-2681(19)31490-5","article-title":"Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease","volume":"11","author":"Chavez-Tapia","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.diabres.2020.108080_b0020","article-title":"Association of cholecystectomy with metabolic syndrome in a Chinese population","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2020.108080_b0025","doi-asserted-by":"crossref","first-page":"G413","DOI":"10.1152\/ajpgi.00435.2012","article-title":"Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients","volume":"304","author":"Sonne","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.diabres.2020.108080_b0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2006.01.026","article-title":"Gallbladder disease is associated with insulin resistance in a high risk Hispanic population","volume":"45","author":"Nervi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2020.108080_b0035","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"China noncommunicable disease surveillance G: prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108080_b0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12944-017-0525-3","article-title":"Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study","volume":"16","author":"Cortes","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabres.2020.108080_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1753-0407.12108","article-title":"Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study","volume":"6","author":"Bi","year":"2014","journal-title":"J Diabet"},{"key":"10.1016\/j.diabres.2020.108080_b0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijcard.2014.01.073","article-title":"The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study","volume":"172","author":"Lu","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2020.108080_b0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1753-0407.12240","article-title":"Diabetes and cancer: findings from the REACTION studyREACTION","volume":"7","author":"Ning","year":"2015","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2020.108080_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108080_b0065","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabres.2020.108080_b0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/db08-1607","article-title":"Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men","volume":"58","author":"Stancakova","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108080_b0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabet. Care"},{"key":"10.1016\/j.diabres.2020.108080_b0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population","volume":"108","author":"Ruhl","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2020.108080_b0085","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabres.2020.108080_b0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/dc12-0246","article-title":"Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese Americans","volume":"36","author":"Hayashi","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108080_b0095","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/j.2040-4603.2016.tb00717.x","article-title":"Functions of the Gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.diabres.2020.108080_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MOG.0000000000000416","article-title":"Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship","volume":"34","author":"Arrese","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.diabres.2020.108080_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2017.95","article-title":"Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms","volume":"98","author":"Chen","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.diabres.2020.108080_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2017.129","article-title":"Cholecystectomy: a way forward and back to metabolic syndrome?","volume":"98","author":"Garruti","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.diabres.2020.108080_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.diabres.2020.108080_b0120","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2020.108080_b0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","article-title":"Perspective: TGR5 (Gpbar-1) in liver physiology and disease","volume":"36","author":"Keitel","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.diabres.2020.108080_b0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2020.108080_b0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/mp700105z","article-title":"Mini-review: endocrine actions of fibroblast growth factor 19","volume":"5","author":"Jones","year":"2008","journal-title":"Mol Pharm"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719315335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719315335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:09:57Z","timestamp":1759172997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719315335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"alternative-id":["S0168822719315335"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108080","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737377467.793571073","asserted-by":"object"}]},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholecystectomy is an independent factor of enhanced insulin release and impaired insulin sensitivity","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108080"}}